Nadia Warner

Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine

Daniel J. Tenney, Steven M. LeVine, R.E. Rose et al. · Antimicrobial Agents and Chemotherapy · 2004 · 537 citations · Full text

Vaccination, Clinical Emergence, Health Sciences +15

The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound†

Nadia Warner, Stephen Locarnini · Hepatology · 2008 · 220 citations · Full text

The L80I Substitution in the Reverse Transcriptase Domain of the Hepatitis B Virus Polymerase Is Associated with Lamivudine Resistance and Enhanced Viral Replication In Vitro

Nadia Warner, Stephen Locarnini, Michael J. Kuiper et al. · Antimicrobial Agents and Chemotherapy · 2007 · 101 citations · Full text

Viral Replication, Reverse Transcriptase Domain, Hepatitis B +16

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus

Gregor Ebert, Simon Preston, Cody C. Allison et al. · Proceedings of the National Academy of Sciences · 2015 · 94 citations · Full text

Apoptosis, Immunology, Hepatitis B +20

Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21).

Ryan Philip, Ambros Berger, Nancy H. McManus et al. · The Journal of Immunology · 1986 · 78 citations

Down Syndrome, Inflammation, Allergy +15